BME100 f2015:Group17 1030amL1

BME 100 Fall 2015	Home People Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3 Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6 Course Logistics For Instructors Photos Wiki Editing Help
OUR TEAM Name: Your name Name: Your name Name: Your name Name: Your name Name: Your name Name: Your name LAB 1 WRITE-UP Independent and Dependent Variables Independent Variable: Dosage amount The independent variable is the dosage of lipopolysaccharide (lps) because the dosage is what we are physically changing Dependent Variable: the level of inflammatory protein (Inflammotin) The dependent variable changes based on the amount of lipopolysaccharide Experimental Design Groups 6 groups Age Population of 48 Elderly people aged from 60 to 80 years old (volunteers) Number of subjects per group 8 people randomly selected by names being pulled out of a hat Subject Selection randomly selected by names being pulled out of a hat Doses: 0mg, 2mg, 4mg, 6mg, 8mg, 10mg 0mg is the control (placebo) and 10mg is proven to work. The other doses are our test dosages Double Blind study, patients don't know what dosage they are receiving and neither do the scientists who will be administering the drug. Measuring- blood samples using ELISA weekly for 12 weeks measure the amount of the protein before and after taking the pill to realize any increase in protein production. Sources of Error and Bias When the pill is taken Saturday Morning after coming in for testing of protein levels Measurements are weekly before and after taking the pill Diet and Exercise maintain daily lifestyle in order to get eliminating confounding variables This should be done before and after the experiment Patient’s Health Status measuring the protein level before and after receiving doses to see if there is an increase of protein levels In depth medical examination before to test for any health risks that might influence the production of the protein